Share
Stax conducted market research on Donor-Advised Funds (DAFs), holding 50 phone interviews and analyzing an additional 70 vetted survey responses of advisors (e.g., financial advisors, attorneys, accountants) in the New York area.
Our research outlines several key findings. As a preview of what's shared in the report, our survey found that:
- 70% of respondents recommend Donor-Advised Funds (DAFs) to their clients. DAFs are well-established and highly recommended.
- Top reasons to recommend DAFs include:
- Ability to recognize tax deductions in the contribution year and distribute assets over time (80% of respondents).
- Opportunity to establish a legacy of charitable giving (74%).
- Ability to optimize tax liability on appreciated assets (60%).
As part of Stax's research efforts, our goal was to gain a deeper understanding of how we can enhance social impact by leveraging the expertise among financial advisors, accountants, and attorneys, and we found that there is significant opportunity for these advisors to increase their guidance on donor-advised funds.
Read More
Global Practice Leader Paul Edwards explains how diligence is changing and how confidence and conviction are adding exit value. Read the full article here.
Rob Larson met with Carta to discuss the growing problem of supply and demand in the US healthcare system, and how a technological revamp could be necessary. Read the full feature here.
Palash Misra explores how AI is changing the marketing landscape, with portfolio companies potentially rethinking how they reach and convert customers. Read more here.
Palash Misra met with Carta to discuss the role of AI in SaaS investment and how investors are reprioritizing what they value in a business. Read the feature here.
Grant Thornton Stax is proud to have supported MainSail Partners in the strategic combination of MirrorWeb and Red Oak. Click to read more.
Multi-stakeholder models sit at an attractive intersection of fragmented markets and PE investors are looking to capitalize. Click here to read our latest insights on MSMs.